Related Experiment Video

Updated: May 21, 2026

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
06:56

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma

Haihan Song1, Danian Tong, Zhanshan Cha

  • 1Department of Internal Medicine, Emergency Center, Shanghai East Hospital, Tongji University, 150 Jimo Road, Shanghai 200120, China.

Molecular Biology Reports
|June 19, 2012
PubMed

Insights

Genetic variations in the C-X-C chemokine receptor type 5 (CXCR5) gene are associated with increased non-Hodgkin lymphoma (NHL) risk in the Chinese population. Specific CXCR5 polymorphisms and haplotypes may serve as novel biomarkers for NHL susceptibility.

Area of Science:

  • Immunogenetics
  • Oncology
  • Molecular Biology

Background:

  • C-X-C chemokine receptor type 5 (CXCR5) is crucial for immune cell homing to secondary lymphoid organs.
  • Polymorphism studies of the CXCR5 gene are limited, particularly in relation to hematological malignancies.

Purpose of the Study:

  • To investigate the association between CXCR5 gene polymorphisms and the risk of developing non-Hodgkin lymphoma (NHL) in the Chinese population.
  • To identify specific CXCR5 variants or haplotypes that may influence NHL susceptibility.

Main Methods:

  • Genotyping of four CXCR5 polymorphisms (rs148351692C/G, rs6421571C/T, rs80202369G/A, rs78440425G/A) using polymerase chain reaction-restriction fragment length polymorphism.
  • Analysis of 404 NHL cases and 456 healthy controls from the Chinese population.
  • Statistical analysis using the χ(2) test to determine associations between genotypes, haplotypes, and NHL risk.

Main Results:

  • Specific genotypes (rs6421571 CT, rs6421571 TT, rs80202369 AA) and the TGG haplotype (rs6421571, rs80202369, rs78440425) were significantly associated with increased NHL susceptibility.
  • The rs6421571 TT genotype and T allele correlated with advanced Ann Arbor stages and B cell NHL subtypes.
  • The 87 bp region containing rs6421571C/T and rs80202369G/A may possess functional significance in NHL development.

Conclusions:

  • CXCR5 gene polymorphisms, particularly rs6421571 and rs80202369, represent potential novel risk factors for non-Hodgkin lymphoma in the Chinese population.
  • The identified CXCR5 variants and haplotypes could serve as predictive biomarkers for NHL development and progression.
  • Further functional studies are warranted to elucidate the precise mechanisms by which these CXCR5 polymorphisms contribute to NHL pathogenesis.

More Related Videos

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...